• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Jungfraubahn Holding AG

  • ID: 644453
  • April 2015
  • 55 Pages
  • Wright Investors Service

A textual analysis of the financial results for Jungfraubahn Holding AG compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Jungfraubahn Holding AG. There is a textual review of the financial results of Jungfraubahn Holding AG versus Rainbow Tours SA, XiAn Qujiang Cultural Tourism Co Ltd and Unlimited Travel Group UTG AB. The comparative analysis of these companies compares Sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

Switzerland

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Wilderness Holdings Limited - Product Thumbnail Image

    Wilderness Holdings Limited

    • Language: English
    • 54 Pages
    • Published: September 2014
  • Jungfraubahn Holding Acquisition Manual - Product Thumbnail Image Jungfraubahn Holding Acquisition Manual

    Jungfraubahn Holding Acquisition Manual

    • Language: English
    • Published: May 2015
  • Compagnie Du Mont-Blanc - Product Thumbnail Image

    Compagnie Du Mont-Blanc

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • CVC Brasil Operadora E Agencia De Viagens S.A - Product Thumbnail Image

    CVC Brasil Operadora E Agencia De Viagens S.A

    • Language: English
    • 54 Pages
    • Published: April 2015
    • Region: Brazil
    FROM
  • NTS ASA - Product Thumbnail Image

    NTS ASA

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Skistar AB - Product Thumbnail Image

    Skistar AB

    • Language: English
    • 55 Pages
    • Published: May 2015
    FROM
  • Rainbow Tours SA - Product Thumbnail Image

    Rainbow Tours SA

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • Bremer Strassenbahn AG - Product Thumbnail Image

    Bremer Strassenbahn AG

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Bochum-Gelsenkirchener Strassenbahnen Aktiengesellschaft - Product Thumbnail Image

    Bochum-Gelsenkirchener Strassenbahnen Aktiengesellschaft

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • FNM S.p.A. - Product Thumbnail Image

    FNM S.p.A.

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.